irinotecan has been researched along with bmn 673 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Bahrami, A; Benavente, C; Bradley, C; Calabrese, C; Caufield, W; Dyer, MA; Freeman, BB; Gordon, B; Goshorn, R; Griffiths, LM; Hatfield, MJ; Karlström, Å; Loh, A; Miller, GM; Pappo, A; Potter, PM; Sablauer, A; Shelat, AA; Shirinifard, A; Snyder, SE; Stewart, E; Thiagarajan, S; Tsurkan, L; Twarog, NR; Wu, J | 1 |
Bahrami, A; Bishop, MW; Brennan, RC; Campagne, O; Clay, MR; Federico, SM; Furman, WL; Gartrell, J; Godwin, K; Hawkins, D; Helmig, S; Kaste, SC; McCarville, MB; Pappo, AS; Sahr, N; Santana, VM; Shelat, A; Stewart, CF; Stewart, E; Sykes, A | 1 |
Brennan, M; Chmielowski, B; Finn, RS; Glaspy, JA; Goldman, J; Hecht, JR; Konecny, GE; Martinez, D; McCann, KE; O'Brien, N; Price, MM; Singh, AS; Slamon, DJ; Von Euw, E; Wainberg, ZA; Yonemoto, L | 1 |
2 trial(s) available for irinotecan and bmn 673
Article | Year |
---|---|
A phase I trial of talazoparib and irinotecan with and without temozolomide in children and young adults with recurrent or refractory solid malignancies.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Humans; Irinotecan; Male; Neoplasms; Phthalazines; Poly(ADP-ribose) Polymerase Inhibitors; Temozolomide; Young Adult | 2020 |
Preclinical and Clinical Trial Results Using Talazoparib and Low-Dose Chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Irinotecan; Neoplasms; Temozolomide | 2023 |
1 other study(ies) available for irinotecan and bmn 673
Article | Year |
---|---|
Targeting the DNA repair pathway in Ewing sarcoma.
Topics: Animals; Benzimidazoles; Camptothecin; Cell Death; Cell Line, Tumor; Dacarbazine; DNA Breaks, Double-Stranded; DNA Repair; Drug Synergism; Enzyme Inhibitors; Irinotecan; Mice, Nude; Molecular Targeted Therapy; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Sarcoma, Ewing; Temozolomide; Xenograft Model Antitumor Assays | 2014 |